Screener
enGene Therapeutics Inc. ENGN Q4 2025 Annual earnings
Reported December 22, 2025 · Before market open
EPS-$0.73Miss by $0.16
EPS estimate-$0.57
Next report
Date not yet announcedVersus estimates
Diluted EPS
FAQ
- When did enGene Therapeutics Inc. report Q4 2025 earnings?
- enGene Therapeutics Inc. (ENGN) reported Q4 2025 earnings on December 22, 2025 before market open.
- What were enGene Therapeutics Inc.'s Q4 2025 revenue and EPS?
- enGene Therapeutics Inc. reported eps of $-0.73 for Q4 2025.
- Did enGene Therapeutics Inc. beat estimates in Q4 2025?
- EPS missed the consensus estimate of $-0.57 by $0.16.
- How did enGene Therapeutics Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 114.7% from $-0.34.
- Where can I find enGene Therapeutics Inc.'s Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-25-328706) and the 10-K periodic report (0001193125-25-328743) directly on SEC EDGAR. The filing index links above go to sec.gov.
